Zenas BioPharma (ZBIO) Net Income towards Common Stockholders (2023 - 2026)
Zenas BioPharma (ZBIO) posted Net Income towards Common Stockholders of -$111.46 million for Q2 2026, compared with -$52.22 million a year earlier.
Powered by 
Analysis
Zenas BioPharma (ZBIO) Net Income towards Common Stockholders (2023 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Income towards Common Stockholders at Zenas BioPharma was -$484.38 million; for FY2025, it was -$377.74 million.
- In prior years, Zenas BioPharma's Net Income towards Common Stockholders was -$157 million in FY2024 and -$37.12 million in FY2023.
- Quarterly Net Income towards Common Stockholders has run from a low of -$240.44 million in Q4 2025 to a high of $35.61 million in Q3 2023 over five years.
- According to Business Quant data, Net Income towards Common Stockholders for the three prior quarters was -$80.99 million (Q1 2026), -$240.44 million (Q4 2025) and -$51.5 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | Zenas BioPharma | 1.79 Bn | 1.79 Bn | - | -111.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -111.46 Mn |
| Mar 31, 2026 | -80.99 Mn |
| Dec 31, 2025 | -240.44 Mn |
| Sep 30, 2025 | -51.50 Mn |
| Jun 30, 2025 | -52.22 Mn |
| Mar 31, 2025 | -33.57 Mn |
| Dec 31, 2024 | -52.60 Mn |
| Sep 30, 2024 | -38.61 Mn |
| Jun 30, 2024 | -37.98 Mn |
| Mar 31, 2024 | -27.80 Mn |
| Dec 31, 2023 | -24.59 Mn |
| Sep 30, 2023 | 35.61 Mn |
API Access
Zenas BioPharma Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=ZBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "ZBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=ZBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();